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The survival motor neuron (SMN) protein forms the
oligomeric core of a multiprotein complex that func-
tions in spliceosomal snRNP biogenesis. Loss of
function mutations in the SMN gene cause spinal
muscular atrophy (SMA), a leading genetic cause of
infant mortality. Nearly half of the known SMA patient
missense mutations map to the SMN YG-box,
a highly conserved oligomerization domain of
unknown structure that contains a (YxxG)3 motif.
Here, we report that the SMN YG-box forms helical
oligomers similar to the glycine zippers found in
transmembrane channel proteins. A network of tyro-
sine-glycine packing between helices drives forma-
tion of soluble YG-box oligomers, providing a struc-
tural basis for understanding SMN oligomerization
and for relating defects in oligomerization to the
mutations found in SMA patients. These results
have important implications for advancing our under-
standing of SMN function and glycine zipper-
mediated helix-helix interactions.
INTRODUCTION
Spinal muscular atrophy (SMA) is the most common genetic
cause of infant mortality (Markowitz et al., 2012). SMA patients
exhibit muscle weakness and poor muscle tone resulting from
degeneration of a-motor neurons in the spinal cord (Crawford
and Pardo, 1996). In the most severe cases (type I SMA), life
expectancy is limited to 2 years due to difficulties in breathing
and poor airway protection. In most SMA patients, deletions or
mutations in the survival motor neuron (SMN) gene are respon-
sible for the disease (Lefebvre et al., 1995).
Most eukaryotes have a single copy of the SMN gene, which
has been found to be essential in each model organism in which
it has been studied. Humans are unusual in having two copies of
SMN, located in a large inverted duplication on chromosome 5q.
The telomeric SMN1 gene is deleted or mutated in SMA patients,
whereas the centromeric SMN2 gene is generally unaffected and
can be present in multiple copies (Lefebvre et al., 1995; Parsons
et al., 1998). The two genes code for identical proteins of 294Structure 20, 1929–19amino acids, but a silent point mutation in SMN2 leads to exon
7 skipping during pre-mRNA splicing of most transcripts (Lorson
et al., 1999; Monani et al., 1999). The result is a modified and
truncated SMN (SMND7), which is rapidly degraded (Burnett
et al., 2009). SMA patients, therefore, have less functional
SMN due to homozygous mutations in SMN1 and the wild-
type SMN required for survival comes from low levels of correctly
spliced SMN2 transcripts.
SMN forms the oligomeric core of the multiprotein ‘‘SMN
complex’’ that is found both in the cytoplasm and nucleus of
most cells (Paushkin et al., 2002). Although this complex may
havemultiple roles in different tissues, its only well-characterized
function is the ordered assembly of uridine-rich small nuclear
ribonucleoprotein particles, or U-snRNPs (Meister et al., 2001;
Pellizzoni et al., 2002). During the initial stages of snRNP biogen-
esis, seven highly conserved Sm proteins are assembled to form
a ring around the Sm site of U-snRNAs, resulting in a snRNP core
(Will and Lu¨hrmann, 2001). In human cells, snRNA transcripts are
exported from the nucleus to the cytoplasm, where the SMN
complex catalyzes this core assembly reaction. Other steps in
snRNP biogenesis include 50-cap hypermethylation and 30-end
processing of the snRNA, internal snRNAmodification, and addi-
tion of snRNP-specific proteins (Kiss, 2004). In addition to SMN,
seven proteins referred to as ‘‘Gemins,’’ plus the protein Unrip,
contribute to the cytoplasmic phase of snRNP biogenesis.
SMN is oligomeric (Liu et al., 1997; Lorson et al., 1998), form-
ing complexes with unusually large hydrodynamic sizes. The
SMN complex from HeLa cells, for example, has a ribosome-
like sedimentation coefficient of 40S on sucrose gradients
(Paushkin et al., 2002). SMN has three highly conserved domains
(Figure 1A). A short segment near the N terminus is responsible
for binding with high affinity to Gemin2 (Liu et al., 1997). A central
Tudor domain recognizes symmetric dimethylarginine (sDMA)
modifications in arginine/glycine rich regions of a number of
proteins involved in RNA processing, including the Sm proteins
(Brahms et al., 2001; Bu¨hler et al., 1999). A C-terminal domain
referred to as the ‘‘YG-box’’ is thought to be primarily respon-
sible for oligomerization (Lorson et al., 1998; Talbot et al.,
1997). The YG-box sequence contains three overlapping motifs:
GxxxGxxxG, YxxxYxxxY, and SxxxSxxxSxxxT (Figure 1B). The
glycine motif is found in a class of transmembrane (TM) helical
oligomers (Kim et al., 2005), but the tyrosine and serine repeats
are not generally found in membrane-spanning protein seg-
ments. There are currently no structural models of the SMN39, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1929
Figure 1. Conserved Regions of the SMN Protein
(A) Domain structure of SMN. The conserved Gemin2-binding, Tudor, and YG-box domains are indicated. Asterisks indicate the approximate locations of amino
acid changes resulting from reported SMA patient mutations.
(B) Alignment of SMN YG-box sequences from diverse organisms. Residues identical in four out of the six sequences are in boldface type. The S, Y, and G repeat
motifs are indicated. Hs, human; Mm, mouse; Dr, zebrafish; Ce, worm; Dm, fly; Sp, fission yeast.
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SMN Forms Glycine Zipper OligomersYG-box region and no sufficiently similar sequences in available
databases to provide reliable predictions.
Amino acid substitutions arising from SMA patient mutations
are located primarily in the Tudor and YG-box regions of SMN
(summarized by Burghes and Beattie, 2009), with 12 of 25
identified point mutants clustered in the YG-box (Figure 1B).
Some of the YG-box variants have been shown to be defective
in oligomerization (Lorson et al., 1998; Pellizzoni et al., 1999) and
snRNP assembly (Shpargel and Matera, 2005; Wan et al., 2005),
establishing a correlation between loss of oligomerization and
a strong SMA phenotype. It is currently unknown what types
of oligomers are formed by SMN or how many SMA patient
mutations in this region cause defects in the ability of SMN to
self-associate.
To address these questions, we have established model
systems for studying the structural and biochemical properties
of SMN and SMN complex oligomers. We find that both SMN
and the isolated YG-box form oligomeric states ranging from
dimers to octamers, all of which are smaller than that implied
by size-exclusion chromatography experiments. The crystal
structure of a dimeric YG-box construct reveals that this region
of SMN forms glycine zipper oligomers related to those found
in TM helical bundles. Unlike the TM oligomers, however, SMN
uses novel tyrosine-glycine packing to stabilize interhelical
interactions, providing a structural explanation for the highly
conserved tyrosine and glycine repeats found in diverse SMN
orthologs. Alanine scanning mutagenesis of the conserved
region of the SMN YG-box leads to a strong correlation between
the oligomeric properties of the substituted YG-box and interac-
tions observed in the YG-box dimer structure. We have also
analyzed the oligomerization properties of each of the twelve
SMA patient YG-box mutations. Although most SMA substitu-
tions in this region affect oligomerization, some have properties
similar to the wild-type controls. The results suggest that the
SMN YG-box is not simply an oligomerization motif and that
the conserved surfaces generated by YG-box helical oligomers
are likely to be used directly in mediating interactions that are
crucial for the functions of SMN.1930 Structure 20, 1929–1939, November 7, 2012 ª2012 Elsevier LtdRESULTS
The SMN-Gemin2 Complex Forms a Distribution
of Oligomeric States
To determine what types of oligomers are formed by SMN, we
examined the hydrodynamic properties of a SMN-Gemin2
complex that lacks the segment coded by exon 5 of SMN (Fig-
ure 1A). The SMN Dexon5 (SMND5) variant is a naturally occur-
ring isoform (Gennarelli et al., 1995) that resembles SMN from fly
and worm, which lack much of this 32-residue proline-rich
region. The SMND5-Gemin2 complex has improved solubility
at physiological ionic strength and shows a reduced tendency
to aggregate, making it more amenable to solution analyses
than the full length SMN-Gemin2 complex. To simplify our
biophysical investigations, we chose to study the minimal
complex formed by SMND5 and Gemin2 rather than larger com-
plexes containing additional gemins (e.g., Gemin3 and Gemin8)
where expression and purification of adequate soluble material
has been challenging.
The SMND5-Gemin2 complex elutes near the 670 kDa marker
of analytical size-exclusion chromatography (SEC) columns (Fig-
ure 2A). This size estimate implies that ten or more copies of the
59 kDa heterodimer are present in a globular oligomer or that
a smaller oligomer adopts an elongated shape and consequently
a large Stokes radius (Rs). When SEC analysis of this complex is
coupled with multi-angle light scattering detection (SEC-MALS),
the weight-average molecular weight (Mw) distribution calcu-
lated across the peak indicates that multiple species are present
with masses that range from 100 kDa to 300 kDa (Figure 2A).
Thus, the sizes of the majority of SMN-Gemin2 oligomers
present in solution are smaller than that implied by SEC alone.
To further investigate the nature of the SMN complex
oligomers formed, we used sedimentation equilibrium ultracen-
trifugation (Figure 2B). As anticipated, the resulting radial distri-
butions of absorbance data could not be described by a single
species in solution. The data could be adequately fit by a
dimer-tetramer-octamer equilibrium model, which is consistent
with the mass distribution observed by SEC-MALS. However,All rights reserved
Figure 2. Oligomerization of the SMND5-Gemin2 Complex
(A) Size-exclusion chromatography (SEC) of SMND-Gemin2, coupled with
in-line multi-angle light scattering detection (SEC-MALS). The weight-
averaged molecular weight (Mw) of the majority of SMN complex ranges from
100–300 kDa. The elution position of the 670 kDa thyroglobulin marker is
indicated for reference.
(B) Sedimentation equilibrium carried out at four rotor speeds and two
complex concentrations (3.0 and 4.3 mM) at 4C. Radial absorbances for the
4.3 mM concentration are shown. The data cannot be fit well to a single
species. The fit shown is for a dimer-tetramer-octamer equilibrium, with K4–8 =
3 mM and K2–4 = 0.4 mM.
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to the data. It is clear, however, that the SMND5-Gemin2 com-
plex adopts multiple oligomeric states in the nM-mM concen-
tration regime and that these oligomers adopt highly extended
conformations.
A Model System to Study YG-Box Oligomerization
The nonglobular and heterogeneous nature of the SMN-Gemin2
complex has been a major obstacle to obtaining structural
models. To understand the oligomers formed by SMN, we
wanted to be able to study the YG-box region in isolation. We
found that most YG-box fusions with common purification tags
were poorly soluble, as were synthetic YG-box peptides.
However, several constructs fused to the carboxyl terminus ofStructure 20, 1929–19the maltose binding protein (MBP) were very soluble, allowing
us to carry out experiments with the YG-box in the absence of
other regions of SMN. Furthermore, we found that we could
control the types of oligomers formed by changing the length
of the MBP-SMN linker.
As shown in Figure 3,MBP-YG252-294 forms stable tetramers in
solution based on SEC-MALS and SE analyses. Small-angle
X-ray scattering (SAXS) data also indicate a tetramer of MBP-
YG subunits in solution (Figure S1 available online). As a control
for a nonoligomeric fusion, we used the corresponding YG-box
sequence from SMND7, the truncated isoform that is the primary
product of the SMN2 gene. MBP-YGD7252-282 behaves exclu-
sively as a monomer, as expected from previous studies in the
context of full-length SMN (Lorson et al., 1998; Pellizzoni et al.,
1999). Summaries of the hydrodynamic properties of MBP-
YG252-294 and MBP-YGD7252-282 are given in Table S1.
Structure of the SMN YG-Box
In addition to serving as a biochemical handle to study SMN olig-
omerization, the MBP-YG-box fusion provided an opportunity to
attempt crystallization of a SMN YG-box oligomer. We therefore
purified and characterized a series of MBP-YG fusions, where
the MBP-SMN linker was shortened to alter the nature of the
coupling between domains (Figure 3A). Fusions starting from
Asp252 through Asp257 formed tetramers or mixtures of oligo-
mers that included tetramers, but did not form diffraction-quality
crystals. Fusions from Ala258 to Met263 were either monomeric
or formed dimers, and one of the dimeric fusions yielded well-
diffracting crystals. We determined the structure of the MBP-
YG263-294 fusion using molecular replacement of MBP and
refined the structure to 1.9 A˚ resolution. Crystallographic data
are summarized in Table 1 and electron density for the refined
model is shown in Figure 4A.
In the MBP-YG263–294 structure, the SMN YG-box forms
a helical dimer with a right-handed crossing angle (Figure 4B).
The most highly conserved residues in the YG-box are well-
ordered in the structure (Met263-Arg281), but the C-terminal
13 residues are disordered. The intersubunit interactions in the
MBP-YG dimer come almost entirely from the YG-box; there
are no MBP-MBP contacts and only a small number of contacts
between MBP and the dimeric partner YG-box (Figure 4C). The
conserved residues that are not part of the Y-, G-, or S-repeat
motifs form hydrophobic contacts that are characteristic of
helix-helix interactions. The tyrosine and glycine residues,
however, form a network of intersubunit interactions (Figure 5).
Each tyrosine side chain packs against the peptide bond
p-electrons preceding the i+3 glycine residue in the opposing
helix. Each glycine residue also packs against the corresponding
glycine in the opposing helix using the peptide bond that follows
Ca. Together, these interactions provide a structural basis for the
unusual (YxxG)3 motif. The close interaction of helical glycine
residues is similar to that seen in TM helical dimers such as
glycophorin (MacKenzie et al., 1997) and in some soluble
proteins (Kleiger et al., 2002), but here there are three consecu-
tive close Gly-Gly interactions whereas in GxxxG motif dimers
there is normally one close contact with a larger right-handed
crossing angle between helices. The conserved serine and thre-
onine residues do not participate directly in the dimer interface.
Instead, they form a network of hydrogen bonds within each39, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1931
Figure 3. The MBP-YG-Box Model System
(A) Schematic of MPB-YG-box fusions. Tightly coupled fusions with a small number of SMN residues between the MBP C terminus and the conserved region of
the YG-box are restricted to be monomers or dimers. Longer linkers allow higher oligomerization states.
(B) SEC-MALS of MBP-YG252–294 (dark curve) and MBP-YGD7252–282 (light curve). The wild-type YG-box (46 kDa) forms stable tetramers (experimental Mw =
183 kDa) but the corresponding construct containing the sequence from SMND7 is monomeric (Mw = 42 kDa). Mw is the average weight-averaged molecular
weight across the center of the peak.
(C) Sedimentation equilibrium of MBP-YG252–294 carried out at two concentrations (6.3 and 12.6 mM) and four rotor speeds (the 6.3 mM concentration is shown).
The fit shown is for a single species tetramer model with molecular weight = 190 kDa.
See also Figure S1 and Table S1.
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SMN Forms Glycine Zipper Oligomershelix, hydrogen-bonding to the carbonyl oxygens of the i3 resi-
dues (Figure 5).
The SMN YG-box dimer structure provides an explanation for
the variable oligomerization states observed in the MBP-YG
truncation series generated for crystallization trials. When the
linker is sufficiently long, the YG-box is oligomeric but the flexible
nature of the attachment presumably hinders crystallization.
When the linker is shortened, steric effects from MBP favor the
formation of smaller oligomers (Figure 3A). An additional conse-
quence of close MBP-YG coupling is that the YG-box will adopt
an appropriate helical phase tomake oligomeric self-interactions
for only certain fusions, because the YG-box forms a continuous
extension of the MBP carboxyl-terminal helix (Figure 4C). MBP,
therefore, serves to limit the extent of oligomerization for both
the tetrameric and dimeric MBP-YG fusions. When longer linkers
were employed, a wider range of oligomeric states could be
formed that mimic those observed in native SMN. The MBP-
SMN229–294 fusion, for example, forms oligomers spanning
a molecular weight range that corresponds to tetramers through
octamers (Figure S2).
TheSMNYG-BoxFormsGlycineZipperHomo-Oligomers
The GxxxGxxxG motif in the SMN YG-box sequence is found in
a family of TM helical oligomers referred to as ‘‘glycine zippers’’
(Kim et al., 2005). Tetrameric, pentameric, and heptameric
examples of this family are shown in Figure 6. SMN appears to
be the first example of a soluble glycine zipper oligomer, but
with an important difference compared to the TM structures.
The conserved tyrosine residues of the SMN YG-box play
a crucial structural role and, as described below, are for the
most part intolerant to substitution. Although tyrosine is gener-
ally disfavored in the central region of the membrane, phenylala-
nine has been found to be statistically overrepresented in the i3
position relative to glycine in TM helices containing the GxxxG1932 Structure 20, 1929–1939, November 7, 2012 ª2012 Elsevier Ltdmotif (Unterreitmeier et al., 2007), suggesting that TM helices
may use similar types of aromatic-glycine interactions. Studies
on model peptides containing the ‘‘FxxGxxxG’’ motif have
confirmed the strong, stabilizing effect of phenylalanine in this
context (Unterreitmeier et al., 2007). To emphasize the important
and conserved role of tyrosine in the YxxG repeating motif
of the SMN YG-box, we call this oligomerization domain a
‘‘YG-zipper.’’
In TM glycine zipper oligomers, the conserved glycine resi-
dues (that can also be small side chains such as alanine, serine,
or threonine) pack against side chains of an adjacent subunit in
the helical bundle. The structural changes that relate the different
oligomeric forms (i.e., tetramer to pentamer) are subtle, involving
relatively small helical rotations coupled with displacements with
respect to the axis of the helical bundle. Thus, the nature of the
helix-helix interactions are similar in the different glycine zipper
oligomers. The SMN YG-box may be capable of forming higher
order oligomers using a similar scheme, but with tyrosine-glycine
interactions playing a prominent role. Based on this idea, we
constructed a model of a SMN YG-box tetramer in which the
conserved YG-box tyrosines pack against the neighboring i+3
glycine residues in the adjacent helices (Figure S3). As discussed
below, glycine zipper helical bundles represent a plausible
model for higher order SMN oligomers.
YG-Box Residues that Are Important for Oligomerization
To test the relative importance of residues in the SMNYG-box for
oligomerization, we substituted each amino acid from Gly261
through Asn283 with alanine, purified the respective MBP-
YG252–294 fusions, and analyzed their oligomeric properties.
The results are summarized in Figure 7A. For those alanine sub-
stitutions that replace residues that are present andwell-ordered
in the YG dimer structure, the oligomeric states are also indi-
cated in Figure 4B. The Met263, Leu264, Trp267, Tyr268,All rights reserved
Table 1. Crystallographic Data and Results
Diffraction Data
Resolution (A˚) 1.9
Space group C2
Unit cell a = 87.7, b = 65.9, c = 84.9 A˚, b = 110.5
Mosaicity () 0.6
Wavelength (A˚) 0.9792
Completeness (%) 99.4 (98.8)
Rmerge 0.126 (0.560)
Total reflections 204,637
Unique reflections 38,656
I/s 19.7 (2.4)
Redundancy 5.3 (4.7)
Refinement
Rfree
a 0.247 (0.322)
Rwork 0.203 (0.248)
Number of atoms 3,216
Protein 2,625
Solvent 591
Average B factors (A˚2)
Protein 24.9
Solvent 27.4
Rmsd
Bond lengths (A˚) 0.02
Bond angles () 1.98
Rmerge = S jIh  <Ih> j /S Ih, where <Ih> is the average intensity over
symmetry equivalent measurements; R-factor, S jFobs – Fcalcj / S
Fobs, where summation is data used in refinement; Rmsd, root-mean
square deviation. Numbers in parentheses represent values in the high-
est-resolution shell.
aThe summation for Rfree was calculated with 5% of the data.
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SMN Forms Glycine Zipper OligomersGly271, Tyr272, Thr274, and Gly275 alanine substitutions all
disrupt oligomerization, resulting in primarily monomeric MBP-
YG fusions. Each of these residues is strongly conserved among
SMN orthologs (Figure 1B). Three additional alanine substitu-
tions at Met269, Tyr276, and Tyr277 resulted in weakened
oligomerization where the oligomeric species still exists but is
in equilibrium with a significant population of monomer (M269A
and Y276A) or monomer and dimer (Y277A).
With the exception of Tyr277, the residues sensitive to alanine
substitution have clear roles in the YG-box dimer structure (Fig-
ure 4B) and would be predicted to have similar roles in higher
order YG-zipper oligomers (Figures 6 and S3). Met263 and
Trp267 from one helix form a hydrophobic cluster with Leu264
from the partner helix, explaining the importance of these side
chains. The structural roles of Tyr268, Gly271, Tyr272, Gly275,
Tyr276, and Gly279 follow from the Y-G interactions described
above and shown in detail in Figure 5. Loss of either of the first
two tyrosine-glycine contacts is sufficient to disrupt oligomer
formation, emphasizing the critical roles of these residues. The
third pair involving Tyr276 andGly279 appears to havemore flex-
ibility, with the Tyr276 substitution having only a small effect and
the Gly279 substitution having no negative effect. As shown in
Figure 4B, the YG helices begin to diverge at this point in theStructure 20, 1929–19dimer and the Y-G packing is less intimate for Tyr276 and
Gly279. Indeed, worm SMN has alanine at the position corre-
sponding to Gly279 and Tyr276 is leucine in the fly and fission
yeast orthologs (Figure 1B).
Thr274 has a unique role in the YG-box structure, being posi-
tioned to make multiple interactions. In addition to an intrahelical
hydrogen bond to the carbonyl group of Ser270, Thr274 makes
van der Waals contact with Tyr272 from the opposing helix,
one of the critical Y-G partners near the center of the YG-box.
This highly conserved threonine is also positioned to interact
with Tyr277. As shown in Figure 4B, Tyr277 does not participate
directly in the helix-helix interface and would be largely solvent-
exposed in a YG-box dimer. In the crystal structure, MBP
restricts the Tyr277 side-chain rotamers that are accessible.
Rotation of the Tyr277 side chain about the Ca-Cb bond indicates
that a hydrophobic cluster involving Tyr277, Thr274, and Tyr272
can be readily formed. This three-way interaction could explain
why both Tyr277 and Thr274 influence oligomerization. The
Y277A substitution was also the only YG-box mutant that we
studied which produced a substantial amount of a dimeric
MBP-YG-box species in the context of the Asp252-Asn294
construct. This observation is consistent with a minor role for
Tyr277 in stabilizing a YG-box dimer, but a more prominent
role in stabilizing higher order oligomers.
Alanine substitutions of several moderately well-conserved
residues in the YG-box do not strongly affect oligomeriza-
tion. Ile265, Ser266, Met269, Ser270, and His273 are each
solvent-exposed in the dimer structure and play no clear role in
mediating helix-helix interactions. Of these, only the M269A
substitution has a minor effect in destabilizing the MBP-YG
tetramer. This group includes two of the serine residues in the
conserved YG-box serine motif. Ser270 forms a hydrogen-
bond to the backbone carbonyl group of Ser266 on the same
helix, but Ser266 does not make a corresponding hydrogen-
bond to the MBP-derived residue preceding Met263. Thus, the
conserved serines in the YG-box may contribute to local stabili-
zation of the helix, but do not participate directly in oligomeriza-
tion in either the dimer structure or a glycine zipper tetramer
model.
Two less well-conserved residues, Met278 and Phe280, are
also not required for oligomerization, consistent with their
observed positions in the YG-box structural models. Met278 is
solvent exposed, with leucine, glutamine, and glutamic acid
represented in this position among the SMN sequences shown
in Figure 1B. Phe280 is positioned at the oligomerization inter-
face, where it makes only minimal van der Waals contacts with
Arg281. None of the residues outside of the orderedYG-box helix
observed in the crystal structure are sensitive to alanine substitu-
tion, including Arg281 through Asn283. Consistent with these
results, the Q282A substitution has been previously studied in
full-lengthSMNandwas found tobeproficient at self-association
and in interacting with wild-type SMN (Carrel et al., 2006).
Four of the alanine-substituted MBP-YG-box constructs
formed oligomers larger than those observed for the wild-type
control. G261A, S270A, G279A, and N283A all formed a sub-
stantial number of species with molecular weights in the 200–
350 kDa range in addition to an apparent tetramer at 180 kDa.
For the substitutions at Gly261, Ser270, and Gly279, these
effects would be consistent with interactions between YG-box39, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1933
A B C
Figure 4. Structure of the SMN YG-Box
(A) Electron density of the SMN YG-box, near the center of the conserved region. A weighted, 1.9 A˚ resolution 2Fo-Fc map contoured at 1.4s is shown.
(B) Structure of the SMNYG-box dimer. The dimer is right-handed, with a34 interhelical dihedral angle. Conserved tyrosine side chains in the YxxxYxxxYmotif
(Y268, Y272, and Y276) pack against conserved i+3 glycine backbone atoms in the GxxxGxxxG motif (G271, G275, and G279). The a-carbon atoms of these
glycine residues are drawn as a spheres. Oligomeric states of the MBP-YG252–294 constructs with single alanine substitutions were determined by SEC-MALS
analysis and are indicated in parentheses. t, primarily tetramer; m, primarily monomer; e, significant monomer and tetramer; t*, higher order oligomers in the
200–350 kDa range are also present; e*, monomer, dimer, and tetramer species present.
(C) Structure of the MBP-YG-box dimer. The SMN YG-box forms a continuous helix with the C-terminal helix of MBP (colored). The inter-subunit contacts in the
dimer are almost exclusively between YG-box helices. There are no MBP-MBP interactions and few MBP-YG-box interactions.
See also Figure S2.
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SMN Forms Glycine Zipper Oligomersoligomeric surfaces that have gained additional hydrophobic
character. The effect of the N283A substitution was surprising
and suggests that the polar residues at the carboxyl-terminal
end of the YG-box also play a role in modulating the oligomeric
state(s) of SMN.
In addition to the alanine-substitutions within the conserved
region of the SMN YG-box discussed above, we purified and
analyzed a series of C-terminal deletions to determine how
many residues coded by exon 7 (Gly279–Asn294) are required
for stable oligomer formation (Figure 7B). We found that dele-
tions up to Asn283 were tolerated, with MBP-YG252–282 forming
stable oligomers similar to the MBP-YG252–294 construct. Dele-
tion of Gln282 led to a primarily monomeric MBP-YG species
and further truncations yielded high molecular weight aggre-
gates that could not be characterized. Thus, the SMN YG-box
requires at least three residues following conserved Gly279 for
efficient oligomerization, with no apparent consequences when
either of the three is substituted by alanine in the context of
full-length exon 7. For correct cellular localization and func-
tion, however, it appears that at least seven residues following
Gly279 are required, including the moderately well-conserved
QNQKE motif starting at Gln282(Carrel et al., 2006; Hua and
Zhou, 2004; Zhang et al., 2003).
Source of the Oligomerization Defect in SMND7
The majority of SMN derived from the SMN2 gene is translated
from a transcript where exon 7 has been removed during pre-1934 Structure 20, 1929–1939, November 7, 2012 ª2012 Elsevier LtdmRNA splicing (Gennarelli et al., 1995; Lorson et al., 1999;
Monani et al., 1999). The resulting SMND7 contains translated
exons 1–6, plus a four residue EMLA sequence derived from
the normally noncoding exon 8 (Figure 7C). SMND7 has been
shown to be defective in self-interaction assays (Lorson et al.,
1998; Pellizzoni et al., 1999) and shows a reduced hydrodynamic
size compared to wild-type SMN by gel filtration (Pellizzoni
et al., 1999). This isoform is also defective in snRNP assembly
(Shpargel and Matera, 2005; Wan et al., 2005; Winkler et al.,
2005), fails to complement loss of wild-type SMN (Carrel et al.,
2006; Shpargel and Matera, 2005), and is less stable in vivo
(Lorson and Androphy, 2000).
As expected, we found thatMBP-YG252–278-EMLA is defective
in oligomerization (Figure 3B). We were interested in under-
standing the molecular basis of this defect, which in principle
could arise fromamino acid substitutions, truncation, or a combi-
nation of the two. We therefore tested the oligomerization prop-
erties of a series of MBP-YG252–294 mutants involving Gly279
through Asn294 (Figure 7C). The MBP-YG(EMLA) construct
contains SMN residues 252–294 with the four substitutions
found in the SMND7 variant. This protein is monomeric, with
properties identical to that seen for MBP-YGD7. The EMLA
substitutions are therefore sufficient to disrupt oligomerization
in the absence of truncation. The MBP-YG(GMLA) construct
retains the native Gly279 and has oligomerization properties
similar to wild-type MBP-YG, suggesting that it is the G279E
substitution that is primarily responsible for the defect. ThisAll rights reserved
Figure 5. Tyrosine-Glycine Interactions in the YG-Zipper Dimer
A stereo view of the dimer interface in the region including the Tyr268-Gly271 and Tyr272-Gly275 pairs is shown. Note the intimate Gly271-Gly271 and
Gly275-Gly275 packing between helices.
Structure
SMN Forms Glycine Zipper Oligomersinterpretation would be consistent with the YG-box structural
models, which indicate that the long, charged side chain of glu-
tamic acid would not be readily accommodated in the oligomeric
interface. Finally, we tested the MBP-YG252-294 G279E point
mutant and confirmed that it was monomeric. These results,
when combined with the observation that C-terminal truncations
up to Asn283 do not disrupt oligomerization of the YG-box, indi-
cate that the G279E substitution is primarily responsible for
defective oligomerization in SMND7.
SMA Patient Mutations and YG-Box Oligomerization
Nearly half of the missense mutations identified in SMA patients
are located in the SMN YG-box (reviewed in Burghes and Beat-
tie, 2009 and listed in Table 2). The type I mutations Y272C and
G279V have been shown to be defective in their ability to self-
interact in a GST-pulldown assay, whereas the type III mutations
S262I and T274I show milder reductions in self-association
(Lorson et al., 1998). The Y272C mutant was also shown to be
defective in oligomerization based on SEC analysis of purified
protein (Pellizzoni et al., 1999). Neither the Y272C or G279V
mutants rescue SMN depletion in zebrafish (Carrel et al., 2006)
and both have sharply reduced half-lives (Burnett et al., 2009).
Half of the substitutions shown in Table 2 (M263R, Y272C,
M263T, S266P, T274I, and G275S) would be predicted to be
defective in oligomerization based on the YG-box structure
and the results of alanine scanning mutagenesis. On the other
hand, the H273R substitution would be predicted to have little
or no effect on oligomerization.
To test these predictions and to provide insight into the re-
maining patient mutations, we purified MBP-YG252–294 fusions
for each of the amino acid substitutions in Table 2 and deter-
mined their oligomeric states using SEC-MALS. The results are
summarized in Table 2 and Figure 8. With one exception, each
of the mutations predicted to disrupt oligomerization was found
to be monomeric. The T274I mutant showed only a minor oligo-
merization defect, with a reduction in the amount of tetramer and
a corresponding increase in the amount of monomer observedStructure 20, 1929–19on the sizing column. The T274I substitution replaces the threo-
nine hydroxyl group with the hydrophobic ethyl group of isoleu-
cine. Thus, the intrahelical hydrogen bond made by Thr274
would be lost (Figure 5). However, the Thr274 methyl group
would remain in the isoleucine substitution, likely preserving
the hydrophobic contacts made to Tyr272 in the adjacent helix.
The defect in oligomerization observed for the smaller T274A
substitution suggests that these contacts play an important
energetic role. These properties are consistent with the findings
of Lorson et al. (1998), who showed that the T274I substitution
largely retains the ability to self-associate and are consistent
with recent studies involving the corresponding T205I substitu-
tion in fly SMN, which also retains the ability to self-associate
(Praveen et al., 2012). As expected, the H273R mutant has
properties similar to that of the wild-type YG-box. His273 is
solvent-exposed and does not participate in the oligomerization
interface.
Three patient mutations (L260S, S262I, and S262G) are
located immediately N-terminal to Met263, the first YG-box
residue in our structural model. If we assume that the YG-box
helix extends several residues in that direction, then Leu260
would be located at the oligomerization interface and Ser262
would be on a solvent-exposed surface of the helix. Assuming
that this is the case, the L260S substitution would be expected
to be destabilizing and the S262 substitutions should havemilder
effects. This explanation is consistent with the observed oligo-
merization properties (Table 2) and with a previous report that
SMN S262I is only mildly impaired in self-association (Lorson
et al., 1998), but structural investigations that include more
N-terminal residues in the YG-box, along with biochemical anal-
yses of these upstream residues will be required to confirm this
interpretation.
The patient mutations at Gly279 are particularly interesting.
We find that in the context of the MBP-YG model system,
G279V is defective at oligomerization, whereas G279C is cap-
able of forming oligomers that are larger than the tetramers
observed for the wild-type sequence. Modeling indicates that39, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1935
Figure 6. Glycine Zipper Oligomers
The SMN YG-box dimer is shown for comparison in (A). Examples of higher
order glycine zipper oligomer structures are (B) the pore-forming helices from
the KcsA potassium channel tetramer (PDB 1BL8), (C) mechanosensitive
channel MscL pentamer (PDB 1MSL), and (D) mechanosensitive channel
MscS heptamer (PDB 1MXM). Conserved glycine Ca atoms are drawn as red
spheres and for (A), the conserved tyrosine side chains are drawn as sticks.
See also Figure S3.
Structure
SMN Forms Glycine Zipper Oligomersthe bulky valine substitution at Gly279 would force Tyr276 to
adopt an alternative rotamer, most likely resulting in loss of
a productive interaction. A cysteine substitution should be better
tolerated in this position, because greater flexibility exists in side
chain positioning compared to valine. However, it is not clear
why larger oligomers form for G279C or for the G279A substitu-
tion, which has similar properties.
DISCUSSION
Our finding that the SMN YG-box forms glycine zipper oligomers
provides important insights into the nature of SMN oligomeriza-
tion and raises a number of intriguing questions. The existing
structural models of glycine zipper oligomers are all found
in membrane proteins that function as channels (Kim et al.,
2005). SMN appears to be the first example of a soluble protein
that uses this class of homo-oligomerization motif. In view of the
known structures of glycine zipper helical bundles, two distinct
models for SMN oligomerization based on YG zippers can be
envisioned. In one model, SMN could form symmetric helical
bundles similar to those shown in Figure 6. This would imply
that the SMN YG-box oligomerizes promiscuously, forming
YG-zipper dimers, tetramers, and possibly other oligomeric
forms. In an alternative model, higher order multimers could
arise from weaker interactions between stable SMN dimers.
Shape reconstructions from SAXS data for the MBP-YG252–294
construct do not readily distinguish between these models
(Figure S1).
Aside from SMN, the (YxxG)3 motif is found in only three
other characterized human proteins: keratin-associated pro-1936 Structure 20, 1929–1939, November 7, 2012 ª2012 Elsevier Ltdtein (GenBank NP_853650), the gap junction protein occlu-
din (NP_002529), and translation initiation factor EIF4B
(NP_001408). In the first two examples, the motif exists in
a low-complexity region rich in tyrosine and glycine (this is also
the case for several hypothetical proteins). Some additional
human proteins also contain this motif, but without the final
glycine. The (YxxG)3 repeat in EIF4B was noted earlier by Talbot
et al. (1997), who also identified the motif in a small number of
RNA-binding proteins from diverse organisms. Thus, unlike the
glycine zipper, which is highly represented inmembrane proteins
(Kim et al., 2005; Senes et al., 2000), the YG-zipper motif does
not appear to be widely used as a biological oligomerization
strategy for soluble proteins. This suggests that the nature of
SMN oligomers may serve a unique functional or architectural
role in the cell.
The EIF4B YG zipper motif occurs with the sequence (YRDG)3,
which in the context of the SMN YG-box dimer structure would
place charged arginine and aspartic acid side chains in
solvent-exposed positions where they could interact to stabilize
a helical YG-zipper-based dimer. Although it remains to be
shown that EIF4B forms YG zipper dimers using this motif, it
has been reported that a 100-residue region that includes the
(YRDG)3 sequence mediates dimerization of the protein and
that this motif is required for oligomer formation (Me´thot et al.,
1996).
An important future goal will be to understand the nature of the
interactions that give rise to the oligomeric heterogeneity found
in SMN complexes. In addition to serving as a self-interaction
module, the conserved surface of the SMN YG-box dimer may
also be used as an interaction site for binding of other compo-
nents in the SMN complex. Indeed, a construct containing the
C-terminal 53 residues of SMN (i.e., only ten residues larger
than that contained in our MBP-YG252–294 construct) has been
reported to be sufficient for interaction with Gemin8 (Otter
et al., 2007). It is also tempting to consider that the unusual
oligomeric properties of SMN are related to its role inmaintaining
the integrity of Cajal bodies and Gems, given that self-associa-
tion appears to be a common feature of major nuclear body
proteins (Hebert and Matera, 2000).
SMA patient mutations mapping to the SMN YG-box result
in a range of oligomeric properties. For substitutions such as
H273R, it seems unlikely that defective oligomerization in vivo
is responsible for the SMA phenotype. In these cases as well
as the YG-box substitutions with intermediate effects on oligo-
merization (e.g., T274I), the altered SMN subunits would be ex-
pected to form mixed oligomers with wild-type SMN arising
from SMN2. SMN complexes in the cells of SMA patients with
these YG-box substitutions are therefore likely to contain both
wild-type and mutant proteins, with ratios that depend on the
SMN2 copy number, cellular levels of the given mutant, and
the energetic contribution to oligomer formation for the SMN
variant versus wild-type SMN. The importance of such hetero-
meric SMN complex formation in the context of SMA has been
previously discussed (Burghes and Beattie, 2009) and a demon-
stration of this effect was shown by allelic complementation in
transgenic mice of SMN2 by SMN1 containing either the A2G
or A111G mutations (Monani et al., 2003; Workman et al., 2009).
The finding that some SMA patient YG-box variants are com-
petent for oligomerization raises the question of what functionalAll rights reserved
AB C
Figure 7. Oligomerization of MBP-YG Mutants
(A) Effects of alanine substitution of residues from Gly261-Asn283 on oligomerization of MBP-YG252–294. These results are also indicated in Figure 4B.
(B) Oligomeric states of C-terminal truncations of MBP-YG252–294.
(C) Oligomeric states of exon 7 substitutions and deletions, using the MBP-YG252–294 construct. Oligomeric states were determined from SEC-MALS analysis of
purified fusion proteins and are defined as in Figure 4B (a, high molecular weight aggregates).
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SMN Forms Glycine Zipper Oligomersdefects could be responsible for the SMA phenotypes. If we
assume that protein levels are not reduced for these mutants
(i.e., lower protein stability or alterations in splicing of the mutant
allele are not responsible for the SMA phenotype), one explana-
tion could be that the YG-box region of SMN also functions as an
interaction surface and one ormore interactions is compromisedTable 2. Oligomerization of MBP-YG252-294 Containing SMA
Patient Mutations
Mutant Typea MBP-YG252–294 SEC-MALS (20C)b
WT Normal tetramer
L260S II (2) monomer
S262G III (1) tetramer
S262I III (1) tetramer+
M263T II (1) monomer
M263R I (2) monomer
S266P II (2) monomer
Y272C I (2) monomer
H273R II (ND) tetramer
T274I III (1) monomer-tetramer
G275S III (ND) monomer
G279C I (ND) tetramer+
G279V I (ND) monomer
aFor each amino acid substitution, type refers to the SMA severity, which
also depends on the number of copies of the SMN2 gene present in the
patient. The copy number associated the givenmutation and type is given
in parentheses, if known. ND = not determined. See Burghes and Beattie
(2009) for further details and references for the individual patient
mutations.
bOligomerization states were categorized based on relative peak heights
from SEC separation together with measured Mw values. Monomer,
primarily monomer; tetramer, primarily tetramer; tetramer+, tetramer
plus higher oligomerization states; monomer-tetramer, significant mono-
mer and tetramer present. These results are mapped onto the YG box
dimer structure in Figure 8.
Structure 20, 1929–19with YG-box substitutions such as H273R. Indeed, the fly T205I
substitution (corresponding to the SMA patient T274I variant)
has been shown to be stable in vivo, suggesting a functional
defect responsible for the mild SMA phenotype observed that
may not be related to oligomerization or stability (Praveen
et al., 2012).
Part of the complexity in relating SMN oligomerization to func-
tional roles in vivo comes from not knowingwhat all of those roles
are and how they may differ in specialized cell types. Even in the
case of snRNP assembly, the oligomeric state of SMN required
for the core assembly steps is not known. It is possible that
different oligomeric forms are involved in core assembly, snRNA
30-processing and cap hypermethylation, nuclear import,
nuclear shuttling, andmaintaining the integrity of gems and Cajal
bodies. The YG zipper model for SMN oligomerization offers
intriguing possibilities to consider what these oligomeric forms
might be and to direct future investigations to understand both
cytoplasmic and nuclear roles of the SMN complex.
EXPERIMENTAL PROCEDURES
Protein Constructs
SMND5-Gemin2 complex was produced by coexpression of SMND5 from
pCDFDuet (Novagen) and Gemin2 from pETDuet (Novagen) as a C-terminal
fusion to the Mxe intein (NEB) containing a hexahistidine tag in strain
BL21(DE3) at 37C with IPTG induction. The complex was purified using
Ni-NTA (QIAGEN) and chitin (NEB) beads, according to vendor protocols.
Eluted protein was further purified using MonoQ anion-exchange chromatog-
raphy (GE Healthcare) using a sodium chloride gradient at pH 8 and gel filtra-
tion using a Superdex 200 (GE Healthcare) column in 20 mM Tris HCl, pH 7.5,
400 mMNaCl, 5 mMDTT. SMND5-Gemin2 complex was >95% pure and con-
tained a 1:1 stoichiometric ratio of SMN/Gemin2 based on Coomassie-stained
SDS-PAGE.
Most MBP-YG-box constructs were expressed as C-terminal Mxe-His6
fusions in pET21a. C-terminal deletions of the MBP-YG-box fusions were con-
structed by insertion of stop codons at the appropriate locations. For all MBP
fusions, the wild-type Escherichia coli MBP sequence lacking the C-terminal
lysine residue was used and proteins were expressed in BL21(DE3) cells at
18C with IPTG induction. Constructs containing the Mxe-His6 tag were puri-
fied using Ni-NTA and chitin beads using vendor protocols. MBP fusions39, November 7, 2012 ª2012 Elsevier Ltd All rights reserved 1937
Figure 8. Effects of SMA Patient Mutations on Oligomerization
The results of SEC-MALS analyses of SMA patient substitutions using
the MBP-YG252–294 construct, mapped onto the YG-box dimer structure.
Defective and intermediate oligomerization properties are colored blue and
gray, respectively.
Structure
SMN Forms Glycine Zipper Oligomerslacking the Mxe-His6 tag were purified on amylose beads (NEB) according to
the vendor’s protocol. All MBP fusions were further purified on a MonoQ
column followed by gel filtration using a Superdex 200 column equilibrated
in 20 mM TrisHCl, pH 7.4, 300 mM NaCl, and 10 mM 2-mercaptoethanol.
MBP-YG fusions were >98% pure as judged by Coomassie-stained SDS-
PAGE.
SEC-MALS
Samples were analyzed at room temperature using a Superdex 200 10/300
analytical size-exclusion column (GEHealthcare) in-line with a DAWNHELEOS
18-angle multi-angle light scattering (MALS) detector and refractive interfer-
ometer (Wyatt Technology). Most experiments were conducted by injecting
1 nmol of MBP-YG fusion (45 mg) or SMND5-Gemin2 complex (60 mg)
onto the column. Protein concentrations of eluate typically ranged from
10–50 mg/ml within the ranges where Mw values could be calculated. SEC-
MALS analyses of complexes containing SMA patient mutations were carried
out by injecting nearly identical quantities of protein to facilitate meaningful
comparison of Mw values and oligomeric states.
Analytical Ultracentrifugation
Sedimentation equilibrium experiments were performed with an XL-A analyt-
ical ultracentrifuge (Beckman) and a TiAn60 rotor with charcoal-filled Epon
centerpieces and quartz windows. Data were measured at 4C after experi-
mental verification that equilibrium had been reached. The radial absorbance
data were globally fit with strict mass conservation using the best fit model
based on good model statistics and visual criteria using SEDPHAT (Vistica
et al., 2004).1938 Structure 20, 1929–1939, November 7, 2012 ª2012 Elsevier LtdStructure Determination
Crystalline plates of MBP-YG263–294 grew after 2 days at 21C by hanging drop
vapor diffusion in 0.1 M TrisHCl, pH 8.0, 14% (w/v) PEG 3350, 10 mM CaCl2,
0.1M KCl, 0.1M (NH4)2SO4, and 18% ethylene glycol and were flash frozen
directly in liquid nitrogen. High resolution diffraction data were measured at
the APS NE-CAT 24-ID-C beam line. Starting phases were obtained at 3 A˚
bymolecular replacement of MBP residues 5–369 (PDB 1OMP). Clear electron
density for the conserved region of the YG-box was visible from the initial
2Fo-Fc map. Iterative refinement with REFMAC (Murshudov et al., 1997) and
model building with COOT (Emsley and Cowtan, 2004) converged to a final
model at 1.9 A˚ with Rwork and Rfree values of 0.203 and 0.247, respectively.
A composite omit map was generated to check the final model, which
includes residues 1–369 of MBP and residues 263–281 of SMN. SMN residues
282–294 are disordered. Ninety-two percent of residues lie in the most favored
region of a Ramachandran plot, and the remaining 8%are in additional allowed
regions.
ACCESSION NUMBERS
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